IPO registrations (S-1, F-1) · Registrants

ADMA BIOLOGICS, INC.

SEC CIK

1368514 · filings on EDGAR ↗

Former names

R&R ACQUISITION VI, INC (2006–2012)

Registration

Form S-1, first filed 2012-03-29, last 2017-11-08; 3 initial registrations, 13 amendments

Outcome

Final prospectus filed 2013-10-17; declared effective 2012-08-13

Industry (SIC)

Biological Products, (No Diagnostic Substances) 2836

Incorporated in

DE

Business address

C/O ADMA BIOLOGICS, INC., 465 STATE ROUTE 17, Ramsey, NJ 07446

EIN

56-2590442

Ticker

ADMA (Nasdaq)

EDGAR entity type

operating

Insiders and CEO pay

ADMA BIOLOGICS, INC. on the corporate pages

Offering terms

Proposed price range

$8.50–$9.50 per share (S-1/A filed 2013-10-04)

Final price

$6.89 per share, below the range (424B4 filed 2013-10-17, an initial public offering)

Shares sold

3,352,941

Gross proceeds

$23,101,763 before underwriting discounts and any over-allotment option

Listing

OTCQB under the symbol ADMA

Lead underwriters

Oppenheimer (1,676,471 shares)

Syndicate

Ladenburg Thalmann (670,588); Maxim Group (670,588); Laidlaw & Company (335,294)

Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.

On this site

• Business registration: ADMA BIOLOGICS, INC. EXACT (EIN (EXACT, as the state registration reports it))
• Business registration: Adma Biologics, Inc. Fuzzy (name and state)
• Business registration: ADMA BIOLOGICS, Inc. Fuzzy (name and state)
• Business registration: ADMA BIOLOGICS, INC. Fuzzy (name and state)
• Business registration: ADMA BIOLOGICS, INC. Fuzzy (name and state)
• Business registration: ADMA BIOLOGICS, INC. Fuzzy (name and state)
• Business registration: ADMA BIOLOGICS, INC. Fuzzy (name and state)
• Form 5500 plan sponsor: ADMA BIOLOGICS, INC. EXACT (EIN (EXACT))
• Federal award recipient: ADMA BIOLOGICS, INC. Fuzzy (name and state)
• Form D issuer: ADMA BIOLOGICS, INC. EXACT (CIK (EXACT))
• SEC filer: ADMA BIOLOGICS, INC. EXACT (CIK (EXACT))
• Person page: Adam S Grossman Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director,Officer))

Filings 26

Prospectus pages read 2

Officers, directors and large holders Forms 3, 4 and 5

Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.

Private offerings before or after (Form D)

Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.

Also on this site Fuzzy

Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.

Others with the same interests

SIC industry Biological Products, (No Diagnostic Substances), NJ first:

• IGX CORP/DE NJ
• Point of Care Nano-Technology, Inc. NJ
• Outlook Therapeutics, Inc. NJ
• Oyster Point Pharma, Inc. NJ
• Kalaris Therapeutics, Inc. NJ
• Tevogen Inc. NJ
• TAMIR BIOTECHNOLOGY, INC. NJ
• GENTA INC DE/ NJ
• BioNTech SE 2M
• Immatics N.V. 2M

More with this interest.

In other datasets, the same topic (Health) in NJ:

• Nonprofit: 1ST CEREBRAL PALSY OF NEW JERSEY INC (Nonprofits (IRS Form 990))

Interests: Biological Products, (No Diagnostic Substances) · Health